CRF Design for Data Standards. David A. Scocca

Similar documents
How to write ADaM specifications like a ninja.

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

Introduction to ADaM and What s new in ADaM

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams

Best Practices for E2E DB build process and Efficiency on CDASH to SDTM data Tao Yang, FMD K&L, Nanjing, China

Cost-Benefit Analysis of Retrospective vs. Prospective Data Standardization

Common Programming Errors in CDISC Data

Examining Rescue Studies

No conflict of interest to disclose

Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA

Legacy to SDTM Conversion Workshop: Tools and Techniques

PharmaSUG Paper PO21

How to review a CRF - A statistical programmer perspective

Study Data Tabulation Model Implementation Guide: Human Clinical Trials Prepared by the CDISC Submission Data Standards Team

Study Data Reviewer s Guide Completion Guideline

Pharmaceuticals, Health Care, and Life Sciences. An Approach to CDISC SDTM Implementation for Clinical Trials Data

Implementing CDISC Using SAS. Full book available for purchase here.

Challenges with the interpreta/on of CDISC - Who can we trust?

Application of SDTM Trial Design at GSK. 9 th of December 2010

SAS CLINICAL SYLLABUS. DURATION: - 60 Hours

Best Practice for Explaining Validation Results in the Study Data Reviewer s Guide

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA

Dealing with changing versions of SDTM and Controlled Terminology (CT)

CTEP, NCI AE Reporting Guidelines and AdEERS

Study Data Reviewer s Guide

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA

DIA 11234: CDER Data Standards Common Issues Document webinar questions

Study Composer: a CRF design tool enabling the re-use of CDISC define.xml metadata

Managing your metadata efficiently - a structured way to organise and frontload your analysis and submission data

Programming checks: Reviewing the overall quality of the deliverables without parallel programming

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA

Considerations on creation of SDTM datasets for extended studies

Implementation of Data Cut Off in Analysis of Clinical Trials

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...

SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components

Standards Driven Innovation

Design of Case Report Forms. Case Report Form. Purpose. ..CRF Official clinical data-recording document or tool used in a clinical study

Traceability Look for the source of your analysis results

ABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets

Research Participant Registration System (RPRS) Study Creation Guide

Customer oriented CDISC implementation

An Efficient Solution to Efficacy ADaM Design and Implementation

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards

Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences

ADaM and traceability: Chiesi experience

Pharmaceutical Applications

A Taste of SDTM in Real Time

Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area

CDISC Standards and the Semantic Web

This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled.

The application of SDTM in a disease (oncology)-oriented organization

Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA

Paper DS07 PhUSE 2017 CDISC Transport Standards - A Glance. Giri Balasubramanian, PRA Health Sciences Edwin Ponraj Thangarajan, PRA Health Sciences

CDISC SDTM and ADaM Real World Issues

AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE

One-PROC-Away: The Essence of an Analysis Database Russell W. Helms, Ph.D. Rho, Inc.

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0

IS03: An Introduction to SDTM Part II. Jennie Mc Guirk

EudraCT release notes

STUDY DATA TECHNICAL CONFORMANCE GUIDE

Clinical Data Acquisition Standards Harmonization (CDASH) User Guide

From ODM to SDTM: An End-to-End Approach Applied to Phase I Clinical Trials

Standardising The Standards The Benefits of Consistency

ADaM Compliance Starts with ADaM Specifications

Codelists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California

The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method

Taming the SHREW. SDTM Heuristic Research and Evaluation Workshop

SERIOUS ADVERSE EVENTS SERIOUS ADVERSE EVENT REPORTING SERIOUS ADVERSE EVENT. Clinical Trials Training Course Serious Adverse Event Reporting

Real Time Clinical Trial Oversight with SAS

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

%check_codelist: A SAS macro to check SDTM domains against controlled terminology

What is high quality study metadata?

Guidance for building Study and CRF in OpenClinica

R1 Test Case that tests this Requirement Comments Manage Users User Role Management

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania

Implementing CDISC at Boehringer Ingelheim

Applying ADaM Principles in Developing a Response Analysis Dataset

What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting

Standardizing FDA Data to Improve Success in Pediatric Drug Development

Introduction to CDASH

PharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania

SCDM 2017 ANNUAL CONFERENCE. September I Orlando

How to handle different versions of SDTM & DEFINE generation in a Single Study?

Lex Jansen Octagon Research Solutions, Inc.

Introduction to ADaM standards

SDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6

ADaM Reviewer s Guide Interpretation and Implementation

CDISC Journal. Generating a cabig Patient Study Calendar from a Study Design in ODM with Study Design Model Extension. By Jozef Aerts.

Johannes Ulander. Standardisation and Harmonisation Specialist S-Cubed. PhUSE SDE Beerse,

DF/HCC Operations for Human Research Subject Registration Procedures

Reporting & Visualisation : D un Dun standard maison au format CDISC 02/02/2016 CDISC GUF 1

OpenCDISC Validator 1.4 What s New?

SDTM-ETL 4.0 Preview of New Features

Specification of a Cardiovascular Metadata Model: A Consensus Standard

SDTM-ETL 3.1 User Manual and Tutorial

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

eirb Electronic Institutional Review Board User Guide For more information contact: Research Administration (803)

Transcription:

CRF Design for Data Standards David A. Scocca dave_scocca@rhoworld.com

CRF Design for Data Standards Controlled Terminology Epochs and Dispositions Dates and Times Free Text Fields Avoiding Unwanted Data Collecting Necessary Context

Where CDASH Fits In Standard for how to collect data, not for what data to collect Provides forms, not a structure within which to present the forms

Controlled Terminology Standardized lists of specific values for data Use standard terminology wherever possible Main SDTM list, with CDASH and ADaM extensions Current CT workbook is always available from National Cancer Institute https://www.cancer.gov/research/resources/terminology/cdisc Many lists are extensible, but not with synonyms e.g, cannot use cc in place of ml

Controlled Terminology

Study Epoch Defined: a period of time that serves a purpose in the trial as a whole Expected for all events, observations, or findings during the trial Does not depend on arm can be determined while data is blinded Uses controlled terminology No overlap

Epoch Terminology SCREENING BASELINE TREATMENT FOLLOW-UP RUN-IN WASHOUT INDUCTION TREATMENT CONTINUATION TREATMENT BLINDED TREATMENT OPEN LABEL TREATMENT LONG-TERM FOLLOW-UP

Epoch: What We Need to Know What events define the start and end of each epoch? Informed Consent First Dose Last Dose What epoch is each observation in? Easy when visit and epoch boundaries match (e.g., Day 1 Predose and Day 1 Dose) Difficult when it requires date comparisons

Dispositions What happens to the subject at the end of a study or study period What was the subject s status? (CDASH) Either COMPLETED or a standardized reason for non-completion Completion determined as per protocol Check the Controlled Terminology Can be collected at the end of each epoch

Unscheduled Visits Unscheduled does not mean unexpected What we need to know: In what epoch is the data being collected? What was the previous scheduled visit? What is the purpose of the unscheduled visit? What was collected together? Ideally, allow multiple unscheduled visits so that each visit can be grouped together

Special Case: Rescreening Re-screening is not handled well by the data standards This is actually a special kind of unscheduled visit Use multiple screening visit forms Having a single subject ID with multiple screening visits is much better than establishing an additional ID when a subject is rescreened

Collecting Dates (and Times) Events should have a collection date Forms should clearly distinguish between a data collection date and a finding date Date of sample collection Date of imaging Date of event/treatment Collect times when necessary PK studies Findings repeated within a day

Free Text Fields: Just Say No Data for medical coding AETERM, CMTRT, MHTERM Implicitly coded data Multiple choice with a specify option for some answers Comments No reliable way to analyze text content Comment domain is basically a dumping ground Real data can be missed or lost

Unwanted Data: Con Meds Collect only what you need The general intervention form allows for a lot of information Treatment, dose, units, route, frequency, form, indication, start date, stop date What is your statistician actually going to do with this data? Collecting, cleaning and tabulating unwanted data is expensive! Context for medical coders

Unwanted Data: Con Meds Do we just need to know what the med was and when it was used? Can we generalize some choices? Indication: Adverse Event vs. underlying condition vs. Other Consider using two CM forms Pain Medications vs. Other Medications Use Indication to validate what goes where

Context: Study Criteria Inclusion and Exclusion criteria change over the course of almost every study with protocol revisions. Criteria must be identified at the same level of granularity What protocol version did a subject consent under? Same exact criterion must get same exact result; any different or changed criterion must get something different

CRF Design for Data Standards Standardized data is what will be submitted to the FDA or other agency We want to make converting the data for submission as straightforward as possible Sub-optimal CRF design can cost a lot of time and effort in later parts of the study Involve SDTM experts in your CRF development process